The iCMLf Diagnosis and Testing Program offers seeding grants to hematology institutions in emerging economic regions. The aim of the program is to facilitate the diagnosis, testing and long-term disease monitoring of CML patients in emerging economic regions where it is either limited, or not currently available.
Over six years the iCMLf have awarded 48 grants to enable CML diagnostics to be expanded and enhanced at a local level. This gives both physicians and patients the knowledge to make meaningful decisions on treatment. In 2018 the Foundation will offer 10 grants with funding of up to $10,000.
Applications will close on the 30th of July 2018. Proposals are welcome to email@example.com.
Read more for further information on how to apply.
Through the Diagnosis and Testing grants the iCMLf assists centres in the emerging economic regions to enhance facilities at a local level to either, bring high quality testing to the patient, or to develop a low cost strategy for sending patient samples to a central reference laboratory for testing. Developing local diagnostic capacity and resource sustainability are important criteria for these grants.
Previous projects have involved the purchase of equipment and reagents, staff training, education events and resource, sample shipments and patient education.
Institutions awarded grants will partner with a CML centre of excellence to ensure the successful implementation of the proposal and to offer ongoing mentoring and support at a clinical and laboratory level.
Comments from previous grant awardees:
Full application and eligibility criteria for the grants can be found on the program information here:
Along with the application form here:
All questions and submissions should be addressed to: firstname.lastname@example.org.
Applications will close on the 30th of July 2018. The selection of 2018 grants will be held in August.